It is interesting to speculate that the observed hypomethylation of the DNMT3L promoter in normal gut mucosa in the HPS patients identified here, may also play a role in the aberrant de novo establishment of tumour suppressor methylation seen in most CRC. The gene discussed is DNMT3L; the disease is colorectal carcinoma.